HOPMAN MARK (Chief Commercial Officer) sold 0.6% of their position (834.00 shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $10.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0002048497-26-000001
Officer· Chief Commercial Officer
Since Mar 2026
+167.02K
Net shares
Net buyer
$10.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
167.85K acquired · 834.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+109.11K
Price / share
—
Trade value
—
% of position
349.5%
2/27/2026
31.21K→140.32K
Common Stock
Direct
Shares
−834.00
Price / share
$12.36
Trade value
$10.31K
% of position
0.6%
3/2/2026
140.32K→139.49K
Total
Net shares
+108.27K
Net value
-$10.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +109.11K | — | — | 349.5% | 31.21K | 140.32K |
| Common Stock Direct | 3/2/2026 | S · Sale | −834.00 | $12.36 | $10.31K | 0.6% | 140.32K | 139.49K |
| Total | +108.27K | -$10.31K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
58.75K shares
Shares
+58.75K
Strike price
12.63
Held after
58.75K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock58.75K shares | 2/27/2026 | A · Award | +58.75K | 12.63 | — | 58.75K |